Osborne Clarke advised Earlybird, Merieux Equity Partners and NRW.BANK on the deal. Prothea Technologies (Prothea), a private medical technology company spun-out of the Universities of Edinburgh...
You must be a Standard 1 Year member to access this content.
Osborne Clarke advised AlbionVC on the deal. Echopoint Medical, a cardiovascular diagnostic technology company and a UCL spinout, has secured £4.2 million in Series A funding...
You must be a Standard 1 Year member to access this content.
Osborne Clarke advised Cherwell Laboratories Limited on the deal. AnalytiChem group acquired Cherwell Laboratories Limited. Cherwell, based in Bicester, Oxfordshire, is a leading provider of cleanroom microbiology...
You must be a Standard 1 Year member to access this content.
Osborne Clarke has advised AlbionVC on investment in OpenDialog AI. OpenDialog AI completed a US$13 million Series A fundraising round. AlbionVC led the investment board, other investors...
You must be a Standard 1 Year member to access this content.
Osborne Clarke advised Albion Capital on the deal. Kennek Solutions completed a £10m funding round. Albion Capital acted as investor on the deal. Other investors included...
You must be a Standard 1 Year member to access this content.
Osborne Clarke advised StudentCrowd on Series A fundraising. StudentCrowd, a decision-making platform for higher education, completed its Series A fundraising round led by Mercia Ventures. With...
You must be a Standard 1 Year member to access this content.
Osborne Clarke advised AlbionVC and Delin Ventures on the deal. AlbionVC and Delin Ventures invested in health and research technology company uMed’s £9.8 million Series A funding round....
You must be a Standard 1 Year member to access this content.
Bass, Berry & Sims advised Williams Sausage Company on the deal. Tyson Foods, Inc. (NYSE: TSN) completed the previously announced acquisition of Williams Sausage Company, Inc....
You must be a Standard 1 Year member to access this content.
Osborne Clarke advised UCL Technology Fund on the investment. Bloomsbury Genetic Therapies Limited (“Bloomsbury”), a clinical-stage biotechnology company developing potentially curative treatments for patients suffering from...
You must be a Standard 1 Year member to access this content.
Withers tech advised Edenred Capital Partners on the deal. Osborne Clarke advised AlbionVC. Edenred Capital Partners invested into 5Mins AI, a microlearning platform that helps employees...
You must be a Standard 1 Year member to access this content.
Osborne Clarke advised King’s College London on the deal. King’s College London established with ValiRx PLC (“ValiRx”) of Cytolytix Limited (“Cytolytix), a new ValiRx subsidiary formed...
You must be a Standard 1 Year member to access this content.
Osborne Clarke has advised a transatlantic syndicate of top-tier life sciences investors including Advent Life Sciences, CTI Life Sciences, Cambridge Innovation Capital and Fonds de solidarité...
You must be a Standard 1 Year member to access this content.
